XuanTai Pharmaceutical

XuanTai Pharmaceutical is a specialty pharmaceutical company headquartered in Nanjing, China, with a strong focus on high-end generic drugs and innovative drug delivery systems. The company excels in developing complex formulations, particularly those requiring advanced solubilization and controlled-release technologies like hot-melt extrusion and osmotic pumps. XuanTai has established a significant presence in both the Chinese and U.S. markets, having successfully obtained multiple ANDA approvals from the FDA. Beyond its internal product development, the company operates as a CDMO, providing integrated R&D and manufacturing services to global pharmaceutical partners. Its therapeutic portfolio primarily covers anti-infectives, cardiovascular health, and central nervous system disorders.